• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

湿热灭菌对含甲磺酸雷沙吉兰的人工合成纳米级固体脂质颗粒的影响。

Effect of the moist-heat sterilization on fabricated nanoscale solid lipid particles containing rasagiline mesylate.

作者信息

Viveksarathi K, Kannan K

机构信息

Department of Pharmacy, Faculty of Engineering and Technology, Annamalai University, Chidambaram, Tamil Nadu, India.

出版信息

Int J Pharm Investig. 2015 Apr-Jun;5(2):87-91. doi: 10.4103/2230-973X.153383.

DOI:10.4103/2230-973X.153383
PMID:25838993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4381391/
Abstract

BACKGROUND

Nanoscale solid lipid particles of rasagiline mesylate (RM) were fabricated by microemulsion technique. The nanoscale particle must be sterile for intravenous administration, and several approaches are available for sterilization. However, the selection of sterilization technique for the fabricated RM loaded nanoscale solid lipid particles mainly depends on the nature of the drug that needs to be encapsulated and release pattern of the polymer.

MATERIALS AND METHODS

We have preferred moist heat sterilization, as it is the most convenient and the composition of the carrier and incorporated drug should remain unchanged and the incorporated drug should not leak out of the drug carrier. The physical and chemical stability of RM loaded nanoscale solid lipid particles investigated during sterilization and to determine the average mean particle size, polydispersity index, zeta potential (ZP), transmission electron microscopy (TEM), entrapment efficiency (EE), and drug content after autoclaving.

RESULT

There were no significant changes in the average mean particle size, polydispersity index, ZP, TEM, EE, and drug content of RM loaded nanoscale solid lipid particles after autoclaving (121°C for 20 min [15 lbs]).

CONCLUSION

These observations suggest that the moist heat sterilization by autoclaving is the most suitable method for nanoscale solid lipid formulations.

摘要

背景

采用微乳技术制备了甲磺酸雷沙吉兰(RM)纳米级固体脂质颗粒。纳米级颗粒用于静脉给药时必须无菌,有几种灭菌方法可供选择。然而,为制备的载RM纳米级固体脂质颗粒选择灭菌技术主要取决于需要包封的药物的性质以及聚合物的释放模式。

材料与方法

我们选择湿热灭菌,因为它最方便,且载体和包封药物的成分应保持不变,包封药物不应从药物载体中泄漏。在灭菌过程中研究了载RM纳米级固体脂质颗粒的物理和化学稳定性,并测定了高压灭菌后的平均粒径、多分散指数、zeta电位(ZP)、透射电子显微镜(TEM)、包封率(EE)和药物含量。

结果

高压灭菌(121°C,20分钟[15磅])后,载RM纳米级固体脂质颗粒的平均粒径、多分散指数、ZP、TEM、EE和药物含量均无显著变化。

结论

这些观察结果表明,高压湿热灭菌是纳米级固体脂质制剂最合适的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11c/4381391/40f0cdc1bbbf/IJPI-5-87-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11c/4381391/e1b48d9a5572/IJPI-5-87-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11c/4381391/f0da80c9a839/IJPI-5-87-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11c/4381391/1438af40c87c/IJPI-5-87-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11c/4381391/d18d1f4ff9fc/IJPI-5-87-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11c/4381391/40f0cdc1bbbf/IJPI-5-87-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11c/4381391/e1b48d9a5572/IJPI-5-87-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11c/4381391/f0da80c9a839/IJPI-5-87-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11c/4381391/1438af40c87c/IJPI-5-87-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11c/4381391/d18d1f4ff9fc/IJPI-5-87-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d11c/4381391/40f0cdc1bbbf/IJPI-5-87-g007.jpg

相似文献

1
Effect of the moist-heat sterilization on fabricated nanoscale solid lipid particles containing rasagiline mesylate.湿热灭菌对含甲磺酸雷沙吉兰的人工合成纳米级固体脂质颗粒的影响。
Int J Pharm Investig. 2015 Apr-Jun;5(2):87-91. doi: 10.4103/2230-973X.153383.
2
Multi criteria decision making to select the best method for the preparation of solid lipid nanoparticles of rasagiline mesylate using analytic hierarchy process.使用层次分析法进行多标准决策,以选择制备甲磺酸雷沙吉兰固体脂质纳米粒的最佳方法。
J Adv Pharm Technol Res. 2014 Jul;5(3):115-21. doi: 10.4103/2231-4040.137410.
3
Effect of sterilization on the physical stability of brimonidine-loaded solid lipid nanoparticles and nanostructured lipid carriers.消毒对载布比卡因固体脂质纳米粒和纳米结构脂质载体物理稳定性的影响。
Int J Pharm. 2015 Dec 30;496(2):976-83. doi: 10.1016/j.ijpharm.2015.10.043. Epub 2015 Oct 21.
4
Nanostructured Lipid Carriers Loaded with Baicalin: An Efficient Carrier for Enhanced Antidiabetic Effects.载有黄芩苷的纳米结构脂质载体:一种增强抗糖尿病作用的高效载体。
Pharmacogn Mag. 2016 Jul-Sep;12(47):198-202. doi: 10.4103/0973-1296.186347.
5
Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?载克霉唑固体脂质纳米粒(SLNs)和纳米结构脂质载体(NLCs)的制备、表征及比较评价:NLCs 是否优于 SLNs?
Eur J Pharm Sci. 2012 Aug 30;47(1):139-51. doi: 10.1016/j.ejps.2012.05.010. Epub 2012 Jun 1.
6
Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.通过基于胆酸钠 - 磷脂酰胆碱的混合胶束负载胰岛素的固体脂质纳米粒:制备与表征
Int J Pharm. 2007 Aug 1;340(1-2):153-62. doi: 10.1016/j.ijpharm.2007.03.009. Epub 2007 Mar 12.
7
Production of Isotonic, Sterile, and Kinetically Stable Lipid-Core Nanocapsules for Injectable Administration.用于注射给药的等渗、无菌且动力学稳定的脂质核纳米胶囊的制备。
AAPS PharmSciTech. 2017 Jan 1;18(1):212-223. doi: 10.1208/s12249-016-0493-3. Epub 2016 Mar 8.
8
Systematic Development of Sertraline Loaded Solid Lipid Nanoparticle (SLN) by Emulsification-Ultrasonication Method and Pharmacokinetic Study in Sprague-Dawley Rats.采用乳化-超声法系统研制舍曲林负载固体脂质纳米粒(SLN)及其在Sprague-Dawley大鼠中的药代动力学研究。
Pharm Nanotechnol. 2019;7(2):162-176. doi: 10.2174/2211738507666190327145628.
9
Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application.载酮康唑的纳米结构脂质载体(NLC)制剂的开发用于肺部应用。
Int J Pharm. 2011 Oct 31;419(1-2):329-38. doi: 10.1016/j.ijpharm.2011.07.040. Epub 2011 Aug 3.
10
Effect of lipid matrix on repaglinide-loaded solid lipid nanoparticles for oral delivery.脂质基质对用于口服给药的瑞格列奈载药固体脂质纳米粒的影响。
Ther Deliv. 2010 Jul;1(1):63-73. doi: 10.4155/tde.10.7.

引用本文的文献

1
Impact of Vehicle Composition on Solubility, Autoclave Sterilization Stability, and Antibacterial Activity of Ciprofloxacin Hydrochloride Ear Drops.载体组成对盐酸环丙沙星滴耳液溶解度、高压灭菌稳定性及抗菌活性的影响
Int J Mol Sci. 2025 May 7;26(9):4458. doi: 10.3390/ijms26094458.
2
Nanotechnology-based drug delivery for the treatment of CNS disorders.基于纳米技术的药物递送用于治疗中枢神经系统疾病。
Transl Neurosci. 2022 Dec 31;13(1):527-546. doi: 10.1515/tnsci-2022-0258. eCollection 2022 Jan 1.
3
The Effect of Polymers on Drug Release Kinetics in Nanoemulsion Gel Formulation.

本文引用的文献

1
Multi criteria decision making to select the best method for the preparation of solid lipid nanoparticles of rasagiline mesylate using analytic hierarchy process.使用层次分析法进行多标准决策,以选择制备甲磺酸雷沙吉兰固体脂质纳米粒的最佳方法。
J Adv Pharm Technol Res. 2014 Jul;5(3):115-21. doi: 10.4103/2231-4040.137410.
2
Preparation and characterization of curcumin-piperine dual drug loaded nanoparticles.姜黄素-胡椒碱双药负载纳米颗粒的制备与表征
Asian Pac J Trop Biomed. 2012 Nov;2(11):841-8. doi: 10.1016/S2221-1691(12)60241-X.
3
New surface-modified solid lipid nanoparticles using N-glutaryl phosphatidylethanolamine as the outer shell.
聚合物对纳米乳液凝胶制剂中药物释放动力学的影响。
Polymers (Basel). 2022 Jan 21;14(3):427. doi: 10.3390/polym14030427.
4
Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs.纳米颗粒在抗帕金森病药物递送中的重要性。
Pharmaceutics. 2021 Apr 8;13(4):508. doi: 10.3390/pharmaceutics13040508.
5
Nanopharmaceuticals for Eye Administration: Sterilization, Depyrogenation and Clinical Applications.眼部给药的纳米药物:灭菌、去热原及临床应用
Biology (Basel). 2020 Oct 14;9(10):336. doi: 10.3390/biology9100336.
使用 N-谷氨酰化磷脂酰乙醇胺作为外壳的新型表面修饰固体脂质纳米粒。
Int J Nanomedicine. 2011;6:2393-401. doi: 10.2147/IJN.S20849. Epub 2011 Nov 1.
4
An effective novel delivery strategy of rasagiline for Parkinson's disease.一种用于治疗帕金森病的雷沙吉兰的有效新型递药策略。
Int J Pharm. 2011 Oct 31;419(1-2):271-80. doi: 10.1016/j.ijpharm.2011.07.029. Epub 2011 Jul 22.
5
Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery.利多卡因脂质纳米系统的构建与评价及其经皮给药
AAPS PharmSciTech. 2009;10(3):985-92. doi: 10.1208/s12249-009-9287-1. Epub 2009 Jul 30.
6
Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer.聚环氧乙烷修饰的聚己内酯纳米颗粒用于他莫昔芬在乳腺癌中的靶向递送
Int J Pharm. 2005 Apr 11;293(1-2):261-70. doi: 10.1016/j.ijpharm.2004.12.010.
7
PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution.含吡喹酮的聚乳酸-羟基乙酸共聚物纳米颗粒:制剂变量对粒径分布的影响
Int J Pharm. 2005 Feb 16;290(1-2):137-44. doi: 10.1016/j.ijpharm.2004.11.027. Epub 2005 Jan 13.
8
Solid lipid nanoparticles for parenteral drug delivery.用于肠胃外给药的固体脂质纳米粒
Adv Drug Deliv Rev. 2004 May 7;56(9):1257-72. doi: 10.1016/j.addr.2003.12.002.
9
Biodegradable polymeric nanoparticles as drug delivery devices.可生物降解的聚合物纳米颗粒作为药物递送载体。
J Control Release. 2001 Jan 29;70(1-2):1-20. doi: 10.1016/s0168-3659(00)00339-4.
10
Effect of solvent on the preparation of surfactant-free poly(DL-lactide-co-glycolide) nanoparticles and norfloxacin release characteristics.溶剂对无表面活性剂聚(DL-丙交酯-共-乙交酯)纳米颗粒制备及诺氟沙星释放特性的影响
Int J Pharm. 2000 Oct 10;207(1-2):99-108. doi: 10.1016/s0378-5173(00)00537-8.